Others titles

  • Medicare Part D Prescriber Public Use File Data 2013
  • Medicare Provider Utilization And Payment Part D Prescriber Data 2013

Keywords

  • Prescriber Data
  • Prescription Drug Plans
  • Medicare Part D
  • Medicare Advantage
  • Medicare Prescription Drug Coverage
  • Medicare Claims Data
  • Provider Summary

Medicare Part D Prescriber Utilization and Payment Data 2013

The Medicare Part D Prescriber Public Use File provides information on prescription drug events (PDEs) incurred by Medicare beneficiaries with a Part D prescription drug plan for the year 2013. The Part D Prescriber PUF is organized by National Provider Identifier (NPI) and drug name and contains information on drug utilization (claim counts and day supply) and total drug costs.

Log in to download
Complexity

Get The Data

For getting access to data download links please read and accept the end-user license agreement.
Your Data License
  • Research
    Non-Commercial, Share-Alike, Attribution Free Forever
  • Commercial
    Commercial Use, Remix & Adapt, White Label Log in to download

John Snow Labs Standard End User License Agreement

Last updated:January 20, 2021

This Standard End User License Agreement (“EULA”) applies to customers of John Snow Labs Inc. (as defined below), using any product of John Snow Labs Inc. on John Snow Labs Marketplace as defined below (hereinafter referred to “you”) and John Snow Labs Inc., a Delaware corporation (“John Snow Labs”, “we” or “us”).

By downloading, installing, and/or using (as applicable) any Product of John Snow Labs (as defined below), you automatically agree to be bound by, and use our Products in compliance with, this EULA. This EULA, together with additional terms and conditions and/or policies referenced herein or located on https://www.johnsnowlabs.com and/or conveyed to you by John Snow Labs, is a legally binding contract between you and John Snow Labs.

PLEASE READ THIS EULA CAREFULLY BEFORE PURCHASING, INSTALLING OR USING OUR PRODUCTS MADE AVAILABLE ON JOHN SNOW LABS MARKETPLACE.

We may make changes to this EULA from time to time. When we do so, we will revise the “last updated” date given above. The then-current version of this EULA will supersede all earlier versions. You agree that your continued use of our Products after such changes have been published to our EULA will constitute your acceptance of such revised EULA.

Definitions

“John Snow Labs Data Library” means a data library located at https://www.johnsnowlabs.com;

“Products” means products and services of John Snow Labs that you download and use from listings in John Snow Labs Data Library;

Important Notice

By installing and using our Products, you acknowledge that the use of the Products can be subject to the restrictions and controls imposed by United States export regulations.

You represent and warrant that you do not intend to use the Products for any purpose prohibited by United States export regulations, including, without limitation, terrorism, cyber-attacks, cyber-crimes, money-laundering, industrial espionage, or nuclear, chemical or biological weapons proliferation. Further, you represent and warrant that you are not listed as a denied party on any list governing United States exports.

Eligibility

Our Products can be used by an individual, business or other legal entity, or both. If you are entering into this EULA, or using the Products, on behalf of a company or other legal entity, you represent that you have the authority to bind such entity to this EULA, in which case “you” shall refer to such entity.

In the event you have entered into a separate written agreement with John Snow Labs regarding the Products that contemplates terms that are inconsistent with this EULA, the written agreement shall control and this EULA will not apply to you to the extent inconsistent with such written agreement, or, if such written agreement is contemplated to be in lieu of this EULA, then this EULA shall not apply at all.

Your Access and Use

Subject to your compliance with this EULA, as well as any other applicable policies, John Snow Labs grants you non-exclusive, non-transferable, license to install, access to, modify, and use of, the Products worldwide (subject to applicable export laws) during the term of this EULA (as described below) solely for research, private study and personal use of Products.

This license is personal to you, and you may not resell our Products, permit other users access to our Products through your account. Your right to use our Products is limited by all terms and conditions set forth in this EULA.

Except for your pre-existing rights and this license granted to you, we and our licensors retain all rights, titles and interests in and to our Products, all related intellectual property rights, including trademarks (whether registered or pending), domain and business names. Our Products are protected by applicable intellectual property laws, including United States copyright law and international treaties.

Except for the foregoing license, you have no other rights in the Products and you may not modify, edit, copy, reproduce, create derivative works of, reverse engineer, alter, enhance or in any way exploit the Products in any manner. If you breach any of this EULA, the above license will terminate automatically.

You will be deemed to have taken any action that you permit, assist or facilitate any person or entity to take related to this EULA, your content or use of the Products. You are responsible for end users’ use of your content and the Products. You will ensure that all end users comply with your obligations under this EULA and that the terms of your agreement with each end user are consistent with this EULA. If you become aware of any violation of your obligations under this EULA caused by an end user, you will immediately suspend access to your content and the Products by such end user. We do not provide any support or services to end users unless we have a separate agreement with you or an end user obligating us to provide such support or services.

Restrictions

You will access or use our Products solely via John Snow Labs Data Library.

Except as otherwise explicitly provided in this EULA or as may be expressly permitted by applicable law, you will not, and will not permit or authorize any third party to:

  1. reproduce, modify, translate, enhance, decompile, disassemble, reverse engineer or create derivative works of any of our Products or its technological features or measures;
  2. rent, lease, sell, resell, loan, distribute, or sublicense access to any of our Products;
  3. circumvent or disable any security or technological features or measures of our Products;
  4. use our intellectual property rights without our express prior written authorization;
  5. use our Products for more than one trial period, unless the trial period is extended by John Snow Labs’ prior written permit;
  6. use our Products with an intent to build a competitive product or service, or copy or substantially copy any ideas, features, functions, organization, structure, application program interface, graphics, or user interface of the Products;
  7. store, copy, modify, distribute, or resell any of the information; audio, visual, and audiovisual works, or other content made available on our Products (collectively, “Content”) or compile or collect any Content as part of a database or other work;
  8. use any automated tool (e.g., robots, spiders) to access or use our Products, or to store, copy, modify, distribute, or resell any Content;
  9. circumvent or disable any rights management, usage rules, or other security features of our Products;
  10. use our Products in a manner that overburdens, or that threatens the integrity, performance, or availability of, our Products; or
  11. remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Fees and Taxes

Your use of the Products is subject to our fees. All fees are given on our website https://www.johnsnowlabs.com. Except as set forth in this EULA, the fees are non-refundable. We are entitled to revise our fees from time to time.

The fees exclude any federal, state or local taxes, VAT, GST, or similar taxes. You are responsible for identification and payment of all taxes as required by applicable law.

Term and Termination

This EULA will become effective as of the date of your order of Products and shall be in effect until terminated.

John Snow Labs may suspend or terminate your right to use our Products, if you or your end user’s use of the Products:

  1. is in breach of this EULA;
  2. poses a security risk to our Products;
  3. could adversely impact our systems, the Products or other customers;
  4. could subject us, our affiliates, or any third party to liability; or
  5. could be fraudulent.

We may also suspend or terminate your right to use our Products, if you fail to perform your payment obligations, or you have ceased to operate in the ordinary course, made an assignment for the benefit of creditors or similar disposition of your assets, or become the subject of any bankruptcy, reorganization, liquidation, dissolution or similar proceeding.

We may also suspend or terminate your right to use our Products without any reason upon a relevant 30 days’ written notice to you and will refund the unused fees pre-paid by you for access to the Products for the affected time period (if any). Where your access is suspended or terminated by the breach of this EULA or applicable laws, John Snow Labs will will not provide, or be liable for, any refund.

You will cease use of the Products during any period of suspension, or upon termination of this EULA.

All provisions which by their nature are intended to survive termination shall survive termination of this EULA.

Support

If applicable to your Product, John Snow Labs will provide you with the support services. If you use a trial access, support services are excluded. Under this EULA, our support services exclude any installation, training, maintenance services (including any error corrections, bug fixes, or new releases), technical assistance, consulting services, or other services of any kind. Such services are provided at John Snow Labs’ discretion.

From time to time John Snow Labs can perform updates to our software. If available, such updates may include bug fixes, new features and/or enhancements. You are solely responsible for deploying such updates at your own risk and liability.

Access to our Products

We do not provide you with the equipment to access our Products. You are responsible for all fees charged by third parties related to your access and use of our Products (e.g., charges by Internet service providers).

You are responsible for monitoring your use of the Products, including payment of all fees and/or taxes related to such access and use. You agree that John Snow Labs is permitted to request and you hereby consent to provide John Snow Labs information related to your use of the Products for auditing purposes.

You also certify that you are legally permitted to use the Products, and take full responsibility for the selection and use of the Products. This EULA is void where prohibited by law, and the right to use the Products is revoked in such jurisdictions. John Snow Labs makes no claim that the Products may be lawfully used outside of the United States. If you use the Products from outside of the United States, you do so at your own risk and you are responsible for compliance with the laws of jurisdiction.

Privacy Policy

We may collect, store and receive personal and other information about you through our Products. Our collection and use of this information is governed by our Privacy Policy available at https://www.JohnSnowLabs.com/privacy/ which may be amended from time to time.

Links and Third Party Content

Our Products may display, or contain links to, third party products, services, and websites. Any opinions, advice, statements, services, offers, or other information that constitutes part of the content expressed, authored, or made available by other users or other third parties, or which is accessible through or may be located using our Products (collectively, “Third Party Content”) are those of the respective authors or producers and not of us or our shareholders, directors, officers, employees, agents, or representatives.

We do not control Third Party Content and do not guarantee the accuracy, integrity or quality of such Third Party Content. We are not responsible for the performance of, we do not endorse, and we are not responsible or liable for, any Third Party Content or any information or materials advertised in any Third Party Content. By using our Products, you may be exposed to content that is offensive, indecent, or objectionable. We are not responsible or liable, directly or indirectly, for any damage or loss caused to you by your use of or reliance on any goods, services, or information available on or through any third party service or Third Party Content. It is your responsibility to evaluate the information, opinion, advice, or other content available on and through our Products.

Proprietary Rights

John Snow Labs will not obtain any rights under this EULA from you (or your licensors) to your content.

The Products, including software, is and remains the exclusive property of John Snow Labs and its licensors. Except for the access and use rights expressly set forth in this EULA, no license or other rights in or to the Products or John Snow Labs trademark(s) and other intellectual property rights therein, are granted to you, and all such licenses and rights are expressly reserved. You will not remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Trademarks

“John Snow Labs,” the John Snow Labs logo, and any other product, business or service name or slogan, whether registered or pending, displayed on our Products are trademarks of John Snow Labs, Inc. or its suppliers or licensors, and may not be copied, imitated or used, in whole or in part, without the prior written permission of John Snow Labs or the applicable trademark holder. You may not use any metatags or any other “hidden text” utilizing “John Snow Labs” or any other name, trademark or product, business or service name of John Snow Labs without our prior written permission. In addition, the look and feel of our Products, including all page headers, custom graphics, button icons and scripts, is the service mark, trademark and/or trade dress of John Snow Labs and may not be copied, imitated or used, in whole or in part, without our prior written permission. All other trademarks, pending trademarks, registered trademarks, product names and company names or logos mentioned in our Products are the property of John Snow Labs Inc. and/or their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, supplier, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by us.

Disclaimer of Warranties

YOUR USE OF THE PRODUCTS IS AT YOUR SOLE RISK. THE PRODUCTS AND CONTENT EACH ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. WE AND OUR SUPPLIERS AND LICENSORS EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. WE DO NOT GUARANTEE THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THE PRODUCTS OR ANY CONTENT, AND YOU RELY ON THE PRODUCTS AND CONTENT AT YOUR OWN RISK. ANY MATERIAL THAT YOU ACCESS OR OBTAIN THROUGH OUR PRODUCTS IS DONE AT YOUR OWN DISCRETION AND RISK AND YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF ANY MATERIAL THROUGH OUR PRODUCTS. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM US OR THROUGH OR FROM OUR PRODUCTS WILL CREATE ANY WARRANTY NOT EXPRESSLY STATED IN THIS EULA. SOME STATES MAY PROHIBIT A DISCLAIMER OF WARRANTIES AND YOU MAY HAVE OTHER RIGHTS THAT VARY FROM STATE TO STATE.

Limitation of Liability

WE AND OUR SUPPLIERS AND LICENSORS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES (EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF THESE DAMAGES), RESULTING FROM YOUR USE OF OUR PRODUCTS AND CONTENT. UNDER NO CIRCUMSTANCES WILL THE TOTAL LIABILITY OF US AND OUR SUPPLIERS AND LICENSORS OF ALL KINDS ARISING OUT OF OR RELATED TO YOUR USE OF THE PRODUCTS AND CONTENT (INCLUDING BUT NOT LIMITED TO WARRANTY CLAIMS), REGARDLESS OF THE FORUM AND REGARDLESS OF WHETHER ANY ACTION OR CLAIM IS BASED ON CONTRACT, TORT, OR OTHERWISE, EXCEED THE AMOUNTS, IF ANY, THAT YOU HAVE PAID FOR YOUR USE OF THE PRODUCTS AND CONTENT. BECAUSE SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.

Indemnity

To the full extent permitted by applicable law, you shall defend, indemnify and hold harmless John Snow Labs, its affiliates and its licensors, and each of their respective employees, officers, directors, and representatives from and against any claims, damages, losses, liabilities, costs, and expenses (including reasonable attorney’s fees) arising out of or relating to any third party claim concerning: (a) your use of the Products; (b) breach of this EULA or violation of applicable law by you; (c) any content or the combination of such content with other software, content or processes, including any claim involving alleged infringement or misappropriation of third-party rights by such content or combination; or (d) breach of any obligation or duty you owe to a third party.

Legal Notices

Enforcement of this EULA will be governed by the laws of the State of Delaware, excluding its conflict and choice of law principles. The exclusive jurisdiction and venue for any claims arising out of or related to this EULA or your use of the Products will lie in the state and federal courts located in Sussex County, within the State of Delaware, and you irrevocably agree to submit to the jurisdiction of such courts. Our failure to enforce any right or provision in this EULA will not constitute a waiver of such right or provision unless acknowledged and agreed by us in writing. In the event that a court of competent jurisdiction finds any provision of this EULA to be illegal, invalid, or unenforceable, the remaining provisions will remain in full force and effect.

Notifications

We may use your contact information to notify you if we have any legitimate interest or if we need to notify you on any important information related to your use of Products. We will not send you newsletters unless you expressly consented to such notifications.

Contacting Us

If you have any questions or concerns about our Products or this EULA, you may contact us by email at support@JohnSnowLabs.com.

Description

The Part D Prescriber Public Use File (PUF) provides information on prescription drugs prescribed by individual physicians and other healthcare providers and paid for under the Medicare Part D Prescription Drug Program. The Part D Prescriber PUF is based on information from CMS’s Chronic Conditions Data Warehouse, which contains Prescription Drug Event records submitted by Medicare Advantage Prescription Drug (MAPD) plans and by stand-alone Prescription Drug Plans (PDP). The dataset identifies providers by their National Provider Identifier (NPI) and the specific prescriptions that were dispensed at their direction, listed by brand name (if applicable) and generic name. For each prescriber and drug, the dataset includes the total number of prescriptions that were dispensed, which include original prescriptions and any refills, and the total drug cost. The total drug cost includes the ingredient cost of the medication, dispensing fees, sales tax, and any applicable administration fees and is based on the amount paid by the Part D plan, Medicare beneficiary, government subsidies, and any other third-party payers.

Although the Part D Prescriber PUF has a wealth of information on payment and utilization for Medicare Part D prescriptions, the dataset has a number of limitations. Of particular importance is the fact that the data may not be representative of a physician’s entire practice or all of Medicare as it only includes information on beneficiaries enrolled in the Medicare Part D prescription drug program (i.e., approximately two-thirds of all Medicare beneficiaries).

About this Dataset

Data Info

Date Created

2015-04-30

Last Modified

2017-05-25

Version

2017-05-25

Update Frequency

Annual

Temporal Coverage

2013

Spatial Coverage

United States

Source

John Snow Labs; Centers for Medicare and Medicaid Services;

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

Prescriber Data, Prescription Drug Plans, Medicare Part D, Medicare Advantage, Medicare Prescription Drug Coverage, Medicare Claims Data, Provider Summary

Other Titles

Medicare Part D Prescriber Public Use File Data 2013, Medicare Provider Utilization And Payment Part D Prescriber Data 2013

Data Fields

Name Description Type Constraints
National_Provider_IdentifierNational Provider Identifier (NPI) for the performing provider on the claim.string-
Last_Name_Organization_NameWhen the provider is registered in NPPES as an individual, this is the provider’s last name. When the provider is registered as an organization, this is the organization name.string-
First_NameWhen the provider is registered in NPPES as an individual, this is the provider’s first name. When the provider is registered as an organization, this will be blank.string-
Middle_InitialMiddle Initial of the Providerstring-
CredentialsCredentials of the Providerstring-
GenderGender of the Providerstring-
Entity_CodeEntity Type of the Provider, Individual or organizationstring-
Street_Address_1Street Address 1 of the Providerstring-
Street_Address_2Street Address 2 of the Providerstring-
CityThe city where the provider is located, as reported in NPPESstring-
Zip_CodeZip Code of the Providerstring-
State_AbbreviationThe state where the provider is located, as reported in NPPES. The fifty U.S. states and the District of Columbia are reported by the state postal abbreviation.string-
Country_CodeCountry Code of the Providerstring-
Provider_Specialty_TypeProvider Specialty Typestring-
Source_Of_Provider_SpecialtySource of Provider Specialtystring-
Beneficiaries_CountThe total number of unique Medicare Part D beneficiaries with at least one claim for the drug. Counts fewer than 11 are suppressed and are indicated by a blank.integerlevel : Ratio
Total_Claim_CountThe number of Medicare Part D claims. This includes original prescriptions and refills. Aggregated records based on total_claim_count fewer than 11 are not included in the data file.numberlevel : Ratio
Total_Drug_CostThe aggregate total drug cost paid for all associated claims. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees. The total drug cost is based on the amounts paid by the Part D plan, Medicare beneficiary, government subsidies, and any other third-party payers.number-
Total_Day_SupplyThe aggregate number of day’s supply for which this drug was dispensed.numberlevel : Ratio
Beneficiary_Count_Of_Age_65The total number of unique Medicare Part D beneficiaries age 65 and older with at least one claim for the drug. A blank indicates the value is suppressedintegerlevel : Ratio
Supression_Reason_Of_Beneficiary_Count_Age_65A flag indicating the reason the bene_count_ge65 variable is suppressed. * = Primary suppressed due to bene_count_ge65 between 1 and 10. # = Counter suppressed because the “less than 65 year old” group (not explicitly displayed) contains a beneficiary count between 1 and 10, which can be mathematically determined from bene_count_ge65 and bene_count.string-
Total_Claim_Count_Age_65The number of Medicare Part D claims for beneficiaries age 65 and older. This includes original prescriptions and refills. A blank indicates the value is suppressednumberlevel : Ratio
Supression_Reason_Age_65A flag that indicates the reason the variable is suppressed. * = Primary suppressed due to total_claim_count_ge65 between 1 and 10. # = Counter suppressed because the “less than 65 year old” group (not explicitly displayed) contains a small claim count between 1 and 10, which can be mathematically determined from the total_claim_count_ge65 and total_claim_count.string-
Total_Drug_Cost_Age_65The aggregate total drug cost paid for all associated claims for beneficiaries aged 65 and older. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees. If total_claim_count_ge65 is suppressed, this variable is suppressed. A blank indicates the value is suppressed.number-
Total_Day_Supply_Age_65The aggregate number of day’s supply for which this drug was dispensed, for beneficiaries age 65 or older. If total_claim_count_ge65 is suppressed, this variable is suppressed. A blank indicates the value is suppressed.numberlevel : Ratio
Brand_Claim_CountTotal claims of brand-name drugs, including refills. This is based on the Food and Drug Administration approval category of New Drug Application (NDA), NDA authorized generic, or Biologic License Application (BLA). A blank indicates the value is suppressed.numberlevel : Ratio
Brand_Supression_FlagA flag indicating the reason the brand_claim_count and brand_drug_cost variables are suppressed. * = Primary suppressed due to brand_claim_count between 1 and 10. # = Counter suppressed because the claim count from at least one of the corresponding claim count categories (generic_claim_count or other_claim_count) is between 1 and 10. Counter suppression prevents the disclosure of a primary suppressed value when all categories sum to the total value.string-
Brand_Drug_CostAggregate total drug cost paid for brand-name drugs. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees. This is based on the Food and Drug Administration approval category of NDA, NDA authorized generic, or BLA. If brand_claim_count is suppressed this variable is suppressed. A blank indicates the value is suppressed.number-
Generic_Claim_CountTotal claims of generic drugs, including refills. This is based on the Food and Drug Administration approval category of Abbreviated New Drug Application (ANDA). A blank indicates the value is suppressed.numberlevel : Ratio
Generic_Supression_FlagA flag indicating the reason the generic_claim_count and generic_drug_cost variables are suppressed. * = Primary suppressed due to generic_claim_count between 1 and 10. # = Counter suppressed because the claim count from at least one of the corresponding claim count categories (brand_claim_count or other_claim_count) is between 1 and 10. Counter suppression prevents the disclosure of a primary suppressed value when all categories sum to the total value.string-
Generic_Drug_CostAggregate cost paid for generic drugs. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees. This is based on the Food and Drug Administration approval category of ANDA. If generic_claim_count is suppressed this variable is suppressed. A blank indicates the value is suppressed.number-
Other_Claim_CountTotal claims of other drugs, including refills. This is based any other Food and Drug Administration approval categories not included in the brand or generic definitions above. A blank indicates the value is suppressed.numberlevel : Ratio
Other_Supression_FlagA flag indicating the reason other_claim_count and other_drug_cost variables are suppressed. * = Primary suppressed due to other_claim_count between 1 and 10. # = Counter suppressed because the claim count from at least one of the corresponding claim count categories (brand_claim_count or generic_claim_count) is between 1 and 10. Counter suppression prevents the disclosure of a primary suppressed value when all categories sum to the total value.string-
Other_Drug_CostAggregate cost paid for all other drugs not classified as brand or generic. This amount includes ingredient cost, dispensing fee and sales tax. This is based any other Food and Drug Administration approval categories not included in the brand or generic definitions above. If other_claim_count is suppressed this variable is suppressed. A blank indicates the value is suppressed.number-
MAPD_Claim_CountThe number of claims for beneficiaries covered by MAPD plans. A blank indicates the value is suppressed.numberlevel : Ratio
MAPD_Supression_FlagA flag indicating the reason the mapd_claim_count and mapd_drug_cost variables are suppressed. * = Primary suppressed due to mapd_claim_count between 1 and 10. # = Counter suppressed because the pdp_claim_count contains a claim count between 1 and 10, which can be mathematically determined from the mapd_claim_count and total_claim_count.string-
MAPD_Drug_CostAggregate cost paid for claims filled by beneficiaries in MAPD plans. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees. If mapd_claim_count is suppressed this variable is suppressed. A blank indicates the value is suppressed.number-
PDP_Claim_CountThe number of claims for beneficiaries covered by stand-alone PDPs. A blank indicates the value is suppressed.numberlevel : Ratio
PDP_Supression_FlagA flag indicating the reason the pdp_claim_count and pdp_drug_cost variables are suppressed. * = Primary suppressed due to pdp_claim_count between 1 and 10. # = Counter suppressed because the mapd_claim_count contains a claim count between 1 and 10, which can be mathematically determined from the pdp_claim_count and total_claim_count.string-
PDP_Drug_CostAggregate total drug cost paid for claims filled by beneficiaries in stand-alone PDPs. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees. If pdp_claim_count is suppressed this variable is suppressed. A blank indicates the value is suppressed.number-
LIS_Claim_CountTotal number of claims from this prescriber, including refills, for beneficiaries with a Part D low-income subsidy. A blank indicates the value is suppressed.numberlevel : Ratio
LIS_Supression_FlagA flag indicating the reason the lis_claim_count and lis_drug_cost variables are suppressed. * = Primary suppressed due to lis_claim_count between 1 and 10. # = Counter suppressed because nonlis_claim_count contains a claim count between 1 and 10, which can be mathematically determined from the lis_claim_count and total_claim_count.string-
LIS_Drug_CostAggregate total drug cost paid for claims for beneficiaries with a Part D low-income subsidy. This amount includes ingredient cost, dispensing fee and sales tax. If lis_claim_count is suppressed this variable is suppressed. A blank indicates the value is suppressed.number-
Non_LIS_Claim_CountTotal number of claims from this prescriber, including refills, for beneficiaries without a Part D low-income subsidy. A blank indicates the value is suppressed.numberlevel : Ratio
Non_LIS_Supression_FlagA flag indicating the reason the nonlis_claim_count and nonlis_drug_cost variables are suppressed. * = Primary suppressed due to nonlis_claim_count between 1 and 10. # = Counter suppressed because lis_claim_count contains a claim count between 1 and 10, which can be mathematically determined from the nonlis_claim_count and total_claim_count.string-
Non_LIS_Drug_CostAggregate total drug cost paid for claims for beneficiaries without a Part D low income subsidy. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees. If nonlis_claim_count is suppressed this variable is suppressed. A blank indicates the value is suppressed.number-

Data Preview

National Provider IdentifierLast Name Organization NameFirst NameMiddle InitialCredentialsGenderEntity CodeStreet Address 1Street Address 2CityZip CodeState AbbreviationCountry CodeProvider Specialty TypeSource Of Provider SpecialtyBeneficiaries CountTotal Claim CountTotal Drug CostTotal Day SupplyBeneficiary Count Of Age 65Supression Reason Of Beneficiary Count Age 65Total Claim Count Age 65Supression Reason Age 65Total Drug Cost Age 65Total Day Supply Age 65Brand Claim CountBrand Supression FlagBrand Drug CostGeneric Claim CountGeneric Supression FlagGeneric Drug CostOther Claim CountOther Supression FlagOther Drug CostMAPD Claim CountMAPD Supression FlagMAPD Drug CostPDP Claim CountPDP Supression FlagPDP Drug CostLIS Claim CountLIS Supression FlagLIS Drug CostNon LIS Claim CountNon LIS Supression FlagNon LIS Drug Cost
1487724134ABALOS O702 N 13TH STARTESIA882101166NMUSClinic/CenterT152307.58354***#0.00.00.00.015.02307.58#*
1114206109ABBASKOMAILD.M.D.MI620 WING STELGIN601232800ILUSDentistT21420.37403##0.00.0#**#*#
1427392521ABDOUKARAMD.D.SMI105 CENTER CTDANVILLE945061186CAUSDentistT29.035400.71226##*#0.00.0#**#
1700104056ABOUSAMRAMAMDOUMI2044 CRESCENT STASTORIA111053266NYUSPodiatryS15385.81393***#0.00.0**#*
1609187921AHMADNAZISHD.OFI5601 W EUGIE AVEGLENDALE853041255AZUSSpecialistT18391.24462***#0.00.0*##*
1558686055AHMEDAFSHANDDSFI227 N CENTRAL AVEHARTSDALE105301803NYUSDentistT11.015130.3149##*#0.00.0****
1376776153AL-MUFTIFAWAZAMDMI710 W 168TH STNEW YORK100323726NYUSNeurologyS211137.861026**0.00.0#**##*
1386821031ALAMOJOSEID.M.D.MI165 ELMHURSTSTE AKYLE786406396TXUSDentistT19404.4110***#0.00.0*##*
1194955849ALIHAWAAEO.D.FI27792 ALISO CREEK RDSUITE B-124ALISO VIEJO926563833CAUSOptometryS111582.32367****0.00.0****
1114127693ALINOAMANSMDMI9500 EUCLID AVECLEVELAND441956769OHUSGeneral SurgeryS16.026984.7617##*#*0.00.026.0984.7*#